by ZS | Medullan | Jul 15, 2021 | Blogs, Life Sciences, Analytics & Outcomes
Digital health technologies such as sensor-based wearables are maturing from being seen as a hallmark of “boutique” remote monitoring-equipped health services organizations or, alternatively, as the obsession of fitness enthusiasts. Now that they are becoming an...
by Vasundhara Sridharan | Jul 13, 2021 | Blogs, Life Sciences, Analytics & Outcomes
The clinical trial industry has been rapidly transforming from site-based traditional approaches to technology-enabled decentralized processes over the last couple of years. The COVID-19 global pandemic has only fuelled a fire that was already kindled by ballooning...
by ZS | Medullan | Jun 22, 2021 | Life Sciences, Webinars
About this Webinar This webinar highlighted that patient and caregiver voices are critical to building truly inclusive digital health and medicine products and experiences. Knee deep? Just starting out in building digital products in the pharmaceutical and healthcare...
by ZS | Medullan | Jun 10, 2021 | Life Sciences, Webinars
About this Roundtable In digital therapeutics, real-world evidence (RWE) is increasingly important for regulatory and payer decision-making. RWE provides patient-generated data and insights that add value at different stages of an asset’s life cycle. Digital...
by ZS | Medullan | Jun 10, 2021 | Digital Strategy, Life Sciences, Podcasts
Medullan’s Director of Outcomes, Todd Greenwood talks with Jeff Gombala, Associate Principal at ZS Associates, about the emerging opportunities and challenges for using real-world data and evidence in the development of digital therapeutic products. How do we manage...
by Tai Chung | Jun 9, 2021 | Blogs, Life Sciences, Analytics & Outcomes
The fee-for-service reimbursement model dominates the healthcare landscape despite being widely seen as a major culprit for the skyrocketing cost of healthcare over the past three decades. It is a model based on volume — the more services, visits, and episodes or...
